Keyphrases
Plasmodium Falciparum
100%
Atovaquone
100%
Prophylactic Activity
100%
Placebo
33%
Healthy Volunteers
16%
Drug Levels
16%
Polymerase Chain Reaction
16%
Non-immune
16%
Falciparum Malaria
16%
Randomized Double-blind Placebo-controlled Study
16%
Pre-erythrocytic Stages
16%
Parasitemia
16%
Subtherapeutic
16%
Antimalarial Activity
16%
Anopheles Stephensi
16%
Pharmacology, Toxicology and Pharmaceutical Science
Plasmodium falciparum
100%
Atovaquone
100%
Placebo
33%
Infection
16%
Placebo-Controlled Study
16%
Normal Human
16%
Parasitemia
16%
Malaria Falciparum
16%
Antimalarial Activity
16%
Anopheles Stephensi
16%
Immunology and Microbiology
Plasmodium falciparum
100%
Atovaquone
100%
Drug Concentration
16%
Polymerase Chain Reaction
16%
Normal Human
16%
Low Drug Dose
16%
Parasitemia
16%
Antimalarial Activity
16%
Anopheles Stephensi
16%